PCOD, PCOS and PMOS are three names for one condition.
In India all three are in use. A report might say PCOD, a website says PCOS, and the newest papers say PMOS. Nothing about a diagnosis changes between those words.
What the letters actually say
PCOD is polycystic ovarian disease. PCOS is polycystic ovary syndrome. The difference between those two names is one word at the end.
A syndrome is a group of features that turn up together. That is what this is: irregular or absent periods, raised androgens, and the ovarian appearance, in combinations that differ from one person to the next. Not everyone has all three.
PCOD is the older term and it stayed in everyday use in India long after the literature moved on. Plenty of clinics, labs and reports still print it.
Three names, one set of criteria
Whichever word is written at the top of a report, the condition is identified the same way. The Rotterdam criteria are what a diagnosis is made against, and the large Indian prevalence study used them to put the figure at 19.6% of Indian women, close to one in five (Ganie et al., 2024).
So a different name does not mean a different test, a different threshold, or a milder version of the same thing. The name is the only part that varies.
Why there are now three
In May 2026 the condition was renamed again, to Polyendocrine Metabolic Ovarian Syndrome. That decision came out of a consensus process involving 56 organisations and 14,360 survey responses (Teede et al., 2026).
The reasoning is covered in what the rename changed. The short version is that the old name pointed at ovarian cysts, which are not required for a diagnosis, and at one organ, in a condition that works across the hormonal and metabolic systems.
That means PCOD, PCOS and PMOS will all be in circulation for some time. Records and requisitions take years to catch up, and the two older names are what most of the internet still says.
If your reports say PCOD
You can read anything written about PCOS or PMOS as being about your own condition.
Ask at your next appointment which name your records use, so that referrals and test requests stay consistent as you move between a GP, a gynaecologist and an endocrinologist. If you are unsure which of those to see, there is a guide on which doctor handles hormonal symptoms.
Sources2 studies
- Teede HJ, Tassone EC, Brennan L, et al. "Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process." The Lancet. 2026;407:2329–2339. doi:10.1016/S0140-6736(26)00717-8
- Ganie MA, Chowdhury S, Malhotra N, et al. "Prevalence, Phenotypes, and Comorbidities of Polycystic Ovary Syndrome Among Indian Women." JAMA Network Open. 2024;7(10):e2440583. doi:10.1001/jamanetworkopen.2024.40583 The 19.6% figure is from 8,993 women aged 18 to 40 across eight states, assessed under Rotterdam criteria.
Nobody clinical has reviewed this guide.